There are currently no disease - modifying treatments that have been shown to slow the progression or delay the onset of HD in humans; however, several compounds have demonstrated promise in animal models of HD.1 Robust and
sensitive markers of disease progression are required to assess their efficacy in humans.
Not exact matches
Although people with gluten sensitivity may not demonstrate classic symptoms or lab
markers of celiac
disease, gluten nevertheless causes an acute immune response in gluten
sensitive people.
Depression, inflammation, and the clustering
of metabolic risk
markers indicate abnormal functioning
of stress -
sensitive systems.9 These 3 conditions also predict age - related
diseases.